Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis

Endometriosis is a known estrogen-dependent inflammatory disease affecting reproductive-aged women. Common symptoms include pelvic pain, dysmenorrhea, dyspareunia, heavy menstrual bleeding, and infertility. The exact etiology of endometriosis is largely unknown, and, thus, the diagnosis and treatmen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Frontiers in Global Women's Health Ročník 3; s. 856316
Hlavní autoři: Chung, Monica S., Han, Sang Jun
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland Frontiers Media SA 05.04.2022
Frontiers Media S.A
Témata:
ISSN:2673-5059, 2673-5059
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Endometriosis is a known estrogen-dependent inflammatory disease affecting reproductive-aged women. Common symptoms include pelvic pain, dysmenorrhea, dyspareunia, heavy menstrual bleeding, and infertility. The exact etiology of endometriosis is largely unknown, and, thus, the diagnosis and treatment of endometriosis are challenging. A complex interplay of many molecular mechanisms is thought to aid in the progression of endometriosis, most notably angiogenesis. This mini-review examines our current knowledge of the molecular etiology of endometriosis-associated angiogenesis and discusses anti-angiogenic therapy, in the blockade of endometriosis-associated angiogenesis, as potential non-hormonal therapy for the treatment of endometriosis.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
This article was submitted to Quality of Life, a section of the journal Frontiers in Global Women's Health
Reviewed by: Domenico Ribatti, University of Bari Aldo Moro, Italy; Megha Mistry, Norfolk and Norwich University Hospital, United Kingdom
Edited by: Thomas G. Gray, Norfolk and Norwich University Hospital, United Kingdom
ISSN:2673-5059
2673-5059
DOI:10.3389/fgwh.2022.856316